Target intelligence / Profile preview

Sin3A-associated protein 130 (SAP130)

Target
SAP130
Molecular classification
Chromatin-modifying complex subunit, Histone deacetylase complex component, Transcriptional corepressor-associated protein, Other (not an enzyme, receptor, transporter, or ion channel)
01

Overview

Sin3A-associated protein 130 (SAP130) is a core subunit of the histone deacetylase-dependent SIN3A corepressor complex, where it acts as a scaffold and regulatory partner facilitating chromatin remodeling and transcriptional repression through histone and non-histone protein deacetylation. SAP130 binds both the SIN3A scaffold and HDAC1 enzyme within this multi-protein complex and helps stabilize its repressive functions on target genes. It plays a crucial role in epigenetic gene regulation, with evidence from animal models implicating it in heart development and demonstrating that its loss can cause severe developmental syndromes such as hypoplastic left heart syndrome. SAP130 is not a spliceosomal protein (in contrast to the similarly named SF3B3, which was formerly called "spliceosome-associated protein 130" and is a source of literature confusion). SAP130 itself is not a direct drug target or therapeutic biomarker and is considered essential for embryonic development and tissue homeostasis.

Other names
SAP130Sin3A associated protein 130Histone deacetylase complex subunit SAP130130 kDa Sin3-associated polypeptideSin3-associated polypeptide p130Sin3A associated protein 130kDaSAP130phSAP130A0A2R8YDB8C9J683
02

Mechanism of action

Not applicable; SAP130 is not directly targeted by drugs.

03

Biological functions

Transcriptional repressionChromatin remodelingEpigenetic regulationAssembly/enzymatic activity of SIN3A corepressor complexRegulation of cardiac development (zebrafish and mammals)
04

Disease associations

Hypoplastic Left Heart Syndrome (HLHS; implicated through animal models and genetic studies)Pleuropneumonia (database association; evidence base unclear)Other (no major direct links to cancer, inflammation, neurodegenerative disease currently established)
05

Safety considerations

Disruption of SAP130 leads to embryonic lethality in mice, highlighting its essential role in developmentImplicated in congenital defects (particularly heart development) in zebrafish and murine modelsBecause SAP130 is ubiquitously expressed and essential for basic cellular processes, targeting it therapeutically would pose substantial risks to normal tissue function
06

Interacting drugs

None reported.
07

Biomarkers

None established for patient selection or monitoring.

Beyond the preview

Go deeper on Sin3A-associated protein 130 (SAP130).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sin3A-associated protein 130 (SAP130).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call